Recombinant Mouse Alkaline Phosphatase/ALPG Protein，His & GST

Alkaline phosphatase (ALP) is a crucial enzyme involved in various biological processes, including bone mineralization, placental development, and the dephosphorylation of molecules in metabolic pathways. The ALPG isoform, specifically, is associated with osteogenic activity and has garnered significant interest in biomedical research, particularly concerning its roles in skeletal health and disease. Studies have shown that alterations in ALPG expression can be linked to conditions such as osteomalacia and osteoporosis, making it a potential biomarker for bone-related disorders. The recombinant production of ALPG provides a valuable tool for elucidating its functions, interactions, and therapeutic potentials. By expressing ALPG in heterologous systems, researchers can produce large quantities of this protein for structural and functional studies, enabling insights into its catalytic mechanisms and regulatory roles. Furthermore, recombinant ALPG can be applied in drug development and regenerative medicine, particularly in strategies aimed at enhancing bone healing and regeneration. Understanding the nuances of ALPG's activity may lead to novel therapeutic interventions for metabolic bone diseases, thereby addressing a significant public health concern. Overall, the study of ALPG recombinant protein holds promise for advancing knowledge in both basic and applied biomedical sciences.